The clinical study of the coronavirus vaccine has been completed at Moscow Sechenov University. The first group of volunteers will be released on Wednesday July 15, reports RIA Novosti.
Director of the Institute of Medical Parasitology, Tropical and Vector-borne Diseases of the Sechenov University Alexander Lukashev noted that the main purpose of the study was to show the safety of the vaccine for humans.
The volunteers were divided into two groups — the first one received one dose of vaccine, the second received two. The scientist said that all the participants in the trials feel well, although they had high body temperatures in the first days after the vaccination. Even before the start of trials, they were isolated for a long period of time to prevent them from getting infected with coronavirus.
It was isolation that had a negative impact on the psychological state of volunteers: there were conflicts in groups, they had to use psychological help.
Soon the participants of the trials will be able to return to normal life: the discharge is scheduled for July 15 and 20.
“At this stage, the safety of the vaccine was shown… The safety of the vaccine has been confirmed. It corresponds to the safety of those vaccines that are now on the market,” Lukashev said.
Further plan for the development of the vaccine will depend on the epidemiological situation.
In addition to Russia, American scientists are also developing the vaccine against coronavirus. The American company Moderna will conduct final tests of the drug in July.